RxDoctor Payments Data

Tara Masters

Obstetrics & Gynecology · Cookeville, TNNPI 1457427577

Payments from drug & device makers

$2,454in general payments, 2019–2025

Across 104 payments — averaging $23.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$441
  • Sumitomo Pharma America, Inc.$411
  • AbbVie$367
  • Millicent US Inc$187
  • Medtronic$164
  • Sun Pharmaceutical Industries Inc.$160
  • plus $724 from 15 others

What the payments were for

  • Food & beverage$2,06784%
  • Education$38716%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,454 in reported general payments places this provider in the 70th percentile of 763 obstetrics & gynecology providers in Tennessee.

See all obstetrics & gynecology providers in Tennessee

Medicare billing

Part B allowed, 2024
$40,814
Medicare patients
269
Services billed
702

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron46$36,518
GemtesaVibegron20$14,201
Estradiol256$13,857
ProgesteroneProgesterone, Micronized40$1,714
DottiEstradiol12$1,095
Trospium Chloride20$1,087
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst65$752
NitrofurantoinNitrofurantoin Macrocrystal20$632
Methenamine Hippurate12$571
Clobetasol Propionate16$425
Solifenacin Succinate18$299
Medroxyprogesterone Acetate23$193
Hydroxyzine Hcl20$110
Amitriptyline Hcl18$100
Sertraline Hcl14$14

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$441$36,51846 claims
Sumitomo Pharma America, Inc.Gemtesa$411$14,20120 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 763 obstetrics & gynecology providers in Tennessee.

Other obstetrics & gynecology in Cookeville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →